SZSE:002940 (China)
Â
Class A
Â¥
14.77
(-0.67%)
Jun 21
Business Description
Zhejiang AngliKang Pharmaceutical Co Ltd
ISIN : CNE100003GC2
Share Class Description:
SZSE:002940: Class ACompare
Compare
Traded in other countries / regions
002940.China IPO Date
2018-10-23Description
Zhejiang AngliKang Pharmaceutical Co Ltd is engaged in the manufacturing and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The main products offered by the group are cephalosporins antibacterial, angiocarpy drugs and gastrointestinal tract drugs. Geographically, the activities are carried out through Shengzhou, China.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.61 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | 2.83 | |||||
Interest Coverage | 12.56 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.82 | |||||
Beneish M-Score | -2.91 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.1 | |||||
3-Year EBITDA Growth Rate | 4.1 | |||||
3-Year EPS without NRI Growth Rate | -9 | |||||
3-Year FCF Growth Rate | 10.2 | |||||
3-Year Book Growth Rate | 6.3 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.47 | |||||
9-Day RSI | 23.88 | |||||
14-Day RSI | 31.81 | |||||
6-1 Month Momentum % | -14.66 | |||||
12-1 Month Momentum % | -2.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.93 | |||||
Quick Ratio | 1.46 | |||||
Cash Ratio | 1.15 | |||||
Days Inventory | 173.85 | |||||
Days Sales Outstanding | 40.95 | |||||
Days Payable | 173.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.42 | |||||
Dividend Payout Ratio | 0.46 | |||||
3-Year Dividend Growth Rate | -14.3 | |||||
Forward Dividend Yield % | 1.42 | |||||
5-Year Yield-on-Cost % | 1.41 | |||||
Shareholder Yield % | -7.98 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 43.09 | |||||
Operating Margin % | 13.06 | |||||
Net Margin % | 7.43 | |||||
FCF Margin % | 12.6 | |||||
ROE % | 7.58 | |||||
ROA % | 3.93 | |||||
ROIC % | 11.52 | |||||
ROC (Joel Greenblatt) % | 35.07 | |||||
ROCE % | 9.81 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.62 | |||||
PE Ratio without NRI | 22.76 | |||||
Shiller PE Ratio | 22.38 | |||||
Price-to-Owner-Earnings | 91.74 | |||||
PEG Ratio | 7.11 | |||||
PS Ratio | 1.83 | |||||
PB Ratio | 1.86 | |||||
Price-to-Tangible-Book | 2.67 | |||||
Price-to-Free-Cash-Flow | 14.82 | |||||
Price-to-Operating-Cash-Flow | 8.48 | |||||
EV-to-EBIT | 11.98 | |||||
EV-to-EBITDA | 11.98 | |||||
EV-to-Revenue | 1.63 | |||||
EV-to-FCF | 13.57 | |||||
Price-to-Projected-FCF | 1.19 | |||||
Price-to-Graham-Number | 1.64 | |||||
Price-to-Net-Current-Asset-Value | 22.04 | |||||
Earnings Yield (Greenblatt) % | 8.35 | |||||
FCF Yield % | 6.81 | |||||
Forward Rate of Return (Yacktman) % | 8.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang AngliKang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,609.353 | ||
EPS (TTM) (Â¥) | 0.6 | ||
Beta | 0.52 | ||
Volatility % | 32.98 | ||
14-Day RSI | 31.81 | ||
14-Day ATR (Â¥) | 0.57319 | ||
20-Day SMA (Â¥) | 16.328 | ||
12-1 Month Momentum % | -2.32 | ||
52-Week Range (Â¥) | 11.84 - 22.59 | ||
Shares Outstanding (Mil) | 201.73 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zhejiang AngliKang Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zhejiang AngliKang Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Zhejiang AngliKang Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940)'s stock price today?
The current price of SZSE:002940 is ¥14.77. The 52 week high of SZSE:002940 is ¥22.59 and 52 week low is ¥11.84.
When is next earnings date of Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940)?
The next earnings date of Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940) is .
Does Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940) is 1.42% (As of Today), Highest Dividend Payout Ratio of Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940) was 0.68. The lowest was 0.24. And the median was 0.57. The  Forward Dividend Yield % of Zhejiang AngliKang Pharmaceutical Co Ltd(SZSE:002940) is 1.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |